NR3C2 and hydrops fetalis: For hypertensive patients with HF, the 2019 Japanese Society of Hypertension (JSH) guidelines recommend drugs that have been shown to be clinically effective in the treatment of HF, including renin–angiotensin system inhibitors, beta-blockers, and mineralocorticoid receptor blockers (MRBs) [6].